于香港理工大学获生物医学工程博士学位，长期致力于分子影像与纳米医学交叉领域研究，专注于高灵敏度嵌合仿生分子探针的设计开发及疾病诊疗应用。其研究成果显著提升了非侵入性肿瘤监测精度，成功开发的红细胞膜伪装金纳米星探针（发表于《Applied Materials Today》）和脑胶质瘤靶向仿生纳米平台（发表于《Advanced Science》）为早期癌症诊断与光热协同治疗提供了新范式。近五年发表论文15篇，以第一/共一作者在《Advanced Science》《ACS Nano》等TOP期刊发表论文6篇，参与3项国家自然科学基金重点项目。目前研究方向聚焦肿瘤微环境、脑损伤及其相关神经疾病靶向纳米诊疗平台构建，推动"分子探针-多模态成像-智能诊疗"全链条创新体系发展。

Ph.D. in Biomedical Engineering from The Hong Kong Polytechnic University, Dr. Xiazi Huang has long been engaged in interdisciplinary research at the interface of molecular imaging and nanomedicine, with a focus on the design and development of high-sensitivity embedded biomimetic molecular probes for disease diagnosis and therapy. Her research has significantly advanced the precision of noninvasive tumor monitoring. Notably, she developed a red blood cell membrane-camouflaged gold nanostar probe (published in"Applied Materials Toda") and a glioma-targeted biomimetic nanoplatform (published in"Advanced Science"), both offering new paradigms for early cancer diagnosis and photothermal synergistic therapy.

Over the past five years, she has published 15 articles, including 6 as first or co-first author in top-tier journals such as"Advanced Science"and"ACS Nano", and has participated in three Key Projects funded by the National Natural Science Foundation of China. Her current research focuses on the construction of targeted nanotheranostic platforms for the tumor microenvironment, brain injury, and related neurological diseases, aiming to drive the development of an innovative full-spectrum system integrating "molecular probe design – multimodal imaging – intelligent diagnosis and therapy."